Clinical & Experimental Cardiology

Clinical & Experimental Cardiology
Open Access

ISSN: 2155-9880

+44 1300 500008

Research Article - (2018) Volume 9, Issue 4

Myocardial Performance Index in Nephrotic Syndrome

Salah Mohamed Saleh1, Khaled Sayed Mahmoud Elmaghraby2, Ashraf Mohamed Abdelfadil1* and Hanem Saad Mohamed3
1Pediatric Department, Faculty of Medicine, Minia University, Egypt
2Faculty of Medicine, Minia University, Egypt
3Pediatric Registrar, Pediatric Department, Minia University, Egypt
*Corresponding Author: Ashraf Mohamed Abdelfadil, 521, 20th Street, Bolak El Dakror, Giza, 12987, Egypt, Tel: 00201068445424 Email:

Abstract

Background: Primary or idiopathic nephrotic syndrome (PNS) is the most frequent form of Nephrotic Syndrome in children. There is an increased incidence of heart disease in patients with (PNS). Protein wasting and systemic inflammatory activation during PNS may contribute to cardiac remodeling and dysfunction.
Methods: This study was carried out in nephrology unit jointly with cardiology unit in El-Minia University Hospital at the period between March 2015 till December 2016 and included 30 PNS patients as group I and twenty age and sex matched healthy control as group II. Both groups are subjected to full history taking, thorough clinical examination, anthropometric measurements, and lab studies, including serum albumin; renal function tests, 24 h urine protein, and serum cholesterol level. Doppler Echocardiography was used for evaluation of both ventricular hemodynamics, MPI (myocardial performance index) and LV function by LV end systolic diameter, LV end diastolic diameter, LV ejection fraction.
Results: The difference between both groups in conventional echo is non-significant, while it is significant in tissue echocardiography in both ventricles including IVRT, IVCT, MPI, E/A, and DT. Ventricular diastolic dysfunction was detected in 30% of patients in whom; diastolic blood pressure (DBP) was significantly higher than those with normal RV diastolic function. Also, DBP not affected by duration of illness and other biochemical parameters.

Keywords: PNS; Tissue echo; MPI; LV & RV diastolic dysfunction

Introduction

Nephrotic syndrome (NS) is the most common chronic renal disease of childhood and the most common type of NS is PNS [1]. It is caused by impaired glomerular function, characterized by protein leakage from the blood to the urine through the glomeruli, resulting in proteinuria, hypoalbuminemia, hypercholesterolemia and generalized [2]. There is an increased incidence of heart disease in patients with chronic PNS [3]. Protein wasting and systemic inflammatory activation during PNS may contribute to cardiac remodeling and dysfunction [4]. Acute afterload elevations would result in decreased relaxation rate and increased diastolic intolerance to afterload in children with PNS [5].

Subjects and Methods

This study included 50 children and adolescents who were classified into two groups: Group I: 30 patients who had already diagnosed as with primary nephrotic syndrome (18 males, 12 females) their ages ranged from (4-14 y) had regular follow up in pediatric Nephrology outpatients' clinic, jointly with cardiology unit in El-Minia University Hospital at the period between March 2015 till December 2016 and included 2 groups, and Group II: 20 apparently healthy subjects, age and sex matched to the diseased group.

All patients included were those who fulfilled the following criteria: hypoalbuminemia with serum albumin<2.5 g/dl, hypercholesterolemia serum cholesterol>250 mg/dl, generalized edema, proteinuria (urinary protein>2 gm/24 h). Patients excluded if they have congenital or acquired heart diseases, severe anemia, or chronic pulmonary diseases.

The studied groups are subjected to the followings: thorough history taking, clinical examination, and Laboratory investigations, including complete blood count, Liver function tests {serum albumin, alanine aminotransferase (ALT), aspartate amino transferase (AST)}, total cholesterol, urea, and creatinine. Also fresh morning urine sample 10 ml sample was collected and examined for A/C ratio plus 24 h urine collected in a sterile container.

Echocardiography was performed using a Vivid 3 color Doppler ultrasound system General Electric with transducers of 3.75 MHz or 5 MHz, as appropriate for children or adolescents. A complete echocardiographic examination was performed to exclude the possibility of congenital heart disease with great emphasis on RV dimension, global function, and LV internal dimensions with assessment of LV ejection fraction; where recorded images for each patient was stored and analyzed offline with software (Echo PAC; GE Medical Systems, USA) blinded to the patients’ data (Figure 1).

clinical-experimental-cardiology-echocardiographic

Figure 1: Comparison between the patients and the control groups as regard tissue echocardiographic parameters of left ventricle.

From the standard transthoracic windows, LV end diastolic diameter (LVEDD), LV end systolic diameter (LVESD), LV posterior wall (LVPW), and LV ejection fraction (EF) were measured.

Transmitral E wave velocity (E) and (A) wave velocity were obtained from the recorded data and were averaged to generate the mean value (Figure 2).

clinical-experimental-cardiology-right-ventricle

Figure 2: Comparison between the patients and the control as regard tissue echocardiographic parameters of right ventricle.

The MPI, also called Tei index, and is calculated by dividing the sum of IVRT and IVCT by Ejection time (ET). Normally (0.39 ± 0.05) it increases in diastolic dysfunction [6].

LV MPI = (IVCT + IVRT)/LVET

Whereas the preejection time (PEP) derived MPI was defined as the ratio of PEP along with IVRT to ET [7].

We evaluate right ventricular and left ventricular function by MPI. Measurement of the Tei index is noninvasive and easily obtained, it does not require the presence of an echocardiographer with great experience and it does not materially prolong the time required for the examination (Figure 3).

clinical-experimental-cardiology-right-ventricle

Figure 3: Comparison between the patients and the control as regard tissue echocardiographic parameters of right ventricle.

The study was carried out according to the principles of declarations of Helsinki, and its appendices [8] and was approved the hospital ethical review board in El Minia university hospital (code 75a, March, 2015). Written informed consents from patients' caregivers were obtained for the use of their study-related information and for participation in the ongoing research.

Table 1 showed no significant difference between patient and control groups as regard age, sex, weight, height, and SBP and serum creatinine, while there are high significant differences as regard DBP, serum levels of albumin and cholesterol and 24 h urine protein.

 Parameters   Case Control P value
    N=30 N=20
Age Mean ± SD 7.83 ± 3.36 7.05 ± 3.33  
Range 4 – 14 3 – 14 0.4
Sex Number 18 10  
Male Percentage 60% 50% 0.5
Female Number 12 10  
Percentage 40% 50%  
Weight (Kg) Mean ± SD 23.17 ± 7.58 19 ± 8.54 0.07
Range 15 – 40 11 – 40
Height (cm) Mean ± SD 106.5 ± 18.2 104.3 ± 23.5 0.7
Range 84 - -150 66 – 145
SBP (mmHg) Mean ± SD 118 ± 12 115 ± 12 0.5
Range 100 - 140 100 - 130
DBP (mmHg) Mean ± SD 92.75  ± 4.4 75 ± 15 0.001*
Range 60 – 70 50-95
Albumin (g/dl) Mean ± SD 1.8 ± 0.5 4.2 ± 0.5 0.0001*
Range 0-25 3.5-5
Cholesterol (mg/dl) Mean ± SD 374 ± 46.9 155 ± 8.6 0.0001
Range 280 – 490 140 – 170
Creatinine (mg/dl) Mean ± SD 0.713 ± 0.15 0.725 ± 0.16 0.7
Range 0.4 – 1 0.4 – 1
24 h Urine Protein Mean ± SD 6.62 ± 3.85 0.041 ± 0.04 0.0001*
Range 1.3 – 15 0 – 0.11

Table 1: Comparison between patients and control groups in demographic, clinical and laboratory data; DBP: Diastolic Blood Pressure; SBP: Systolic Blood Pressure.

Regarding disease diagnosis, 33.3% patients were steroid responsive NS; 43.3% patients were in relapse after remission; 16.7% patients were SDNS; and 6.7% patient was SRNS.

As shown in Table 2 there was no significant difference between case and control as regard conventional echo parameters, LAD, LVEDD, LVESD, LVPWD, EF and Left DT.

Parameter Case Control P- value
N=30 N=20
L A D Mean ± SD 2.355 ± 0.35 2.103 ± 0.402 0.1
LVEDD Mean ± SD 3.5 ± 0.411 3.52± 0.439 0.9
LVESD Mean ± SD 2.35 ± 0.366 2.39 ± 0.225 0.6
LVPWD Mean ± SD 2.3 ± 9.58 0.55 ± 0.044 4
EF Mean ± SD 65.9 ± 6.88 66.15 ± 4.78 0.9
Left DT Mean ± SD 110 ± 5.783 110.4 ± 5.78 0.8

Table 2: Comparison between case and control groups as regards to conventional echocardiographic parameters; EF: Ejection fraction; LAD: Left Atrial Diameter; Left DT: Left Deceleration Time; LVEDD: Left Ventricular End Diastolic Diameter; LVESD: Left Ventricular End Systolic Diameter; LVPWD: Left Ventricular Posterior Wall Diameter.

As regard tissue echo findings there are significant differences between case and control groups, Lt ventricle (IVRT (P 0.001 ), IVCT (P 0.006), MPI (P 0.001), DT (P 0.02) and E/A Ratio( P 0.002); and in the Rt ventricle, significant differences include, IVRT(P value 0.02), IVCT (P value 0.02) , MPI (P value 0.0001), DT (P value 0.03) and E/A ratio(P value 0.0001) (Table 3).

  Right Ventricle   Left Ventricle  
  Case Control   Case Control  
N=30 N=20 N=30 N=20
Parameter Mean ± SD Mean ± SD P - value Mean ± SD Mean ± SD P - value
ET 243.73 ± 39.8 271 ± 34.54 0.08 202.13 ± 10.7 207.2 ± 13.8 0.02
IVRT 60.2 ± 19.56 52.3 ± 5.06 0.02 144.4 ± 40.87 120.1 ± 19.56 0.02
IVCT 35.467 ± 2.06 34.85 ± 1.14 0.02 60.53 ± 17.32 46.05 ± 7.708 0.001
DT 138.2 ± 36.23 119.7 ± 12.1 0.03 35.73 ± 1.82 34.35 ± 1.39 0.006
MPI 0.47 ± 0.126 0.325 ± 0.53 0.0001 0.473 ± 0.101 0.386 ± 0.047 0.001
E 0.645 ± 0.093 1.07 ± 0.243 0.0001 0.85 ± 0.233 0.808 ± 0.259 0.5
A 0.797 ± 0.459 0.557 ± 0.18 0.003 0.807 ± 0.33 0.596 ± 0.177 0.012
E/A Ratio 0.897 ± 0.365 1.49 ± 0.11 0.0001 1.13 ± 0.447 1.48 ± 0.169 0.002

Table 3: Comparison between the patients and the control as regard tissue echocardiographic parameters of both right and left ventricles; A: A wave; DT: Deceleration time; E: E wave; ET: Ejection Time; IVCT: Isovulemic Contraction time; IVRT: Isovulemic Relaxation time; MPI: ventricular Myocardial Performance Index.

Table 4 shows fair association between LVEDD and Right DT and the duration of the disease and this association is significant (p 0.04, 0.014) respectively.

Spearman's rho EF LVEDD LVESD LVPWD Left DT Right DT
Duration R -0.045 0.376 -0.174 0.064 0.276 0.443
P-value 0.815 0.04* 0.358 0.736 0.139 0.014*

Table 4: Correlation between duration of disease and conventional echocardiographic parameters; DT: Deceleration time; EF: Ejection Fraction; LVEDD: Left Ventricular End Diastolic Dimension; LVESD: Left Ventricular End Systolic Dimensions; LVPWD: Left Ventricular Posterior Wall Diameter.

Table 5 shows fair association between Right A , Right E/A Ratio , Right IVCT and the duration of the disease this association is significant P value (0.042*, 0.034*, 0.019*) respectively. Fair association between Right A, Right E/A Ratio, Right IVCT and the duration of the disease this association is significant.

  Left ventricle Right ventricle
  Duration
Spearman's rho R P- value R P- values
A 0.409 0.025* 0.373 0.042*
E/A -0.263 0.16 -0.388 0.034*
E 0.007 0.969 -0.185 0.328
IVRT 0.353 0.056 0.536 0.002**
IVCT 0.405 0.026* 0.427 0.019*
ET -0.044 0.816 -0.349 0.059
MPI 0.368 0.045* 0.53 0.003**
Tissue DT 0.346 0.061 0.383 0.037

Table 5: Comparison between the patients and the control as regard tissue echocardiographic parameters of both ventricles; A: A wave; DT: Deceleration Time; E: E wave; E/A: E/A ratio; ET: Ejection Time; IVCT: Isovulemic Contraction Time; IVRT: Isovulemic Relaxation Time; MPI: Myocardial Performance Index.

Also Show moderate association between (Right IVRT and Right MPI) and the duration of the disease this association is significant (P 0.002**, 0.003**) respectively.

Grades of correlation (R):

0.24 (no or weak association)

0.25- 0.49 (fair association),

0.50-0.74 (moderate association)

≥ 0.75 (strong association)

Show fair association between Left A, Left IVCT, Left MPI and the duration of the disease this association is significant.

Table 6 Frequency of diastolic dysfunction among nephrotic syndrome patients

Echo parameter Frequency Percentage
Diastolic dysfunction 9 30%
Normal diastolic function 21 70%
Total 30 100%

Table 6: Frequency of diastolic dysfunction among nephrotic syndrome patients; this table showed that 30%of patients with PNS showed ventricular diastolic dysfunction.

As regard echocardiographic study in patients with PNS, we found that 30%of patients with PNS showed ventricular diastolic dysfunction.

Table 7 Comparison between patients with normal ECHO and those with RV diastolic dysfunction.

  ECHO N Mean ± SD P value
Duration of disease (mo) Normal 21 22.57 ± 18.12 0.12
RV diastolic dysfunction 9 20.66 ± 11.27
SBP (mmHg) Normal 21 116.19 ± 13.22 0.17
RV diastolic dysfunction 9 123.33 ± 11.18
DBP (mmHg) Normal 21 69.76 ± 14.62 0.002**
RV diastolic dysfunction 9 87.78 ± 9.72
S albumin (g/dl) Normal 21 1.9 ± 0.398 0.56
RV diastolic dysfunction 9 1.87 ± 0.409
S cholesterol (mg/dl) Normal 21 369.04 ± 42.27 0.38
RV diastolic dysfunction 9 385.56 ± 57.47
S creatinine (mg/dl) Normal 21 0.74 ± 0.12 0.1
RV diastolic dysfunction 9 0.64 ± 0.19

Table 7: Comparison between patients with normal ECHO and those with RV diastolic dysfunction; DBP: Diastolic Blood Pressure; mo: months; S: Serum; SBP: Systolic blood Pressure.

There were no significant differences between patients with RV diastolic dysfunction and those with normal RV diastolic function as regard, duration of illness and other biochemical parameters of PNS. Diastolic blood pressure was significantly increased (P=0.002**) in patients with RV diastolic dysfunction than those with normal RV diastolic function (Figure 4).

clinical-experimental-cardiology-left-ventricle

Figure 4: Frequency of diastolic dysfunction among nephrotic syndrome patient.

Discussion

Our study is a case control one, and included 30 patients with PNS and twenty age and sex matched normal children.

We found significant increase in diastolic blood pressure in patient group than control group (Table 1). Alpert et al. and Bagga et al. found same results especially with steroid resistant NS. This could be due to long term steroid ± cytotoxic therapy, and also due to increased susceptibility of development of chronic renal failure [9-11].

As regard serum albumin, cholesterol, creatinine and 24 h urine proteins as in Table 1) were in accordance with that of Kaan et al. and Ismail et al. [12,13]. Also with Russo et al. who stated that High glomerular permeability leads to hyperalbuminuria and, eventually to hypoalbuminemia [14]; that in turn lowers the plasma colloid osmotic pressure, causing greater transcapillary filtration of water and the development of edema.

Also, regarding Structural changes in the heart (Table 2) were in accordance with the results Qiang Qin et al. who stated that patients with PNS had larger RV dimension by echo compared to normal controls [3]. Also they found out of 50 patients with PNS, RVEDD was increased by average of 20% in 39 patients. In addition, they found that cardiac output & stroke volume were maintained indicating compensation at the expense of increased RVEDD and RVESD.

As regards to left ventricle tissue echocardiographic (Table 3), our results are going with that of Lindblad et al. [9] who found that tissue Doppler imaging (TDI) echo detected early LV diastolic dysfunction, also Correia Pinto et al. [15-17] who stated that afterload elevation could contribute to diastolic dysfunction in the left ventricle and with Tie E Dajardin et al. [18] who reported that systolic dysfunction of the left ventricle increases IVCT and decreases ET, whereas IVRT increases in both systolic and diastolic dysfunction. Egan et al. [19,20] postulated that Cardiac edema could also account for myocardial dysfunction. Where it increases myocardial stiffness and induces contractile dysfunction.

We suggest that increased RV peak pressure and RV end diastolic pressure in children with PNS could be attributed to the following: Impaired functional reserve was highlighted by hemodynamic stress with increased RV end-diastolic pressure, acute afterload elevations would result in decreased relaxation rate and increased diastolic intolerance to afterload in children with PNS. The hemodynamic disturbance was caused by increased diastolic intolerance to afterload. This response to acute afterload can be a precocious sign of dysfunction, preceding overt heart failure Correia Pinto et al. [5]. Second, the elevated RV peak pressure and RV end diastolic pressure could be caused by pulmonary arterial hypertension.

Hypercoagulability can be caused by profound abnormalities in almost all coagulation factors and clotting inhibitors, as well as by defects in platelets and the fibrinolytic system. Although pulmonary embolism appears to be rarer in children than in adults [21]. Its incidence might be underestimated because of the high number of asymptomatic or subclinical events in children with PNS [20].

Our results were unable to identify any relationship between increased pulmonary pressure and the biochemical indicators of thromboembolism studied. This could be because of wide variations in these indicators, or because of the small number of patients with increased pulmonary pressure.

The duration of systemic hypertension might be a more important contributory factor in the increased RV peak pressure and RV enddiastolic pressure than the BP itself, because patients with increased RV peak pressure and RV end-diastolic pressure had longer durations since PNS onset. However, we cannot exclude the possibility that sympathetic activity may have influenced heart function in this study. Further studies are needed to determine the role of sympathetic activity.

Disturbed cardiomyocyte calcium kinetics has also been implicated in myocardial dysfunction during heart failure progression [5].

Conclusion

• RV functions were affected in 30% of children with PNS.

• Elevation of diastolic blood pressure in patients.

• LV and RV dysfunction were significantly correlated with the long duration of the disease

Recommendation

Further studies are needed with larger number of patients, and need long term follow up period, to understand the etiology, clinical implications, and long term prognosis of this abnormality. Also we recommend additional investigation as CT pulmonary angiography. Laboratory studies for better assessment of associated hypercoagulable state and activated cytokines tumor necrosis factor alpha.

Authors’ Contributions

SMS & KEM gives us the idea and suggest plan of work. AM & SMS planned the study. AM, HSM and KEM conducted the study; AM & HSM did analysis data and wrote the paper. AM and KEM are the one responsible for final content. All authors have read and approved the final manuscript.

Ethics Approval and Consent to Participate

The study was carried out according to the principles of declarations of Helsinki, and its appendices [8] and was approved the hospital ethical review board in El Minia university hospital (code 75a, March, 2015). Written informed consents from patients' caregivers were obtained for the use of their study-related information and for participation in the ongoing research.

Acknowledgment

To all medical personnel including doctors and nurses who are working in Nephrology unit, Cardiology unit, and Clinicopathological lab for helping us in our research work. There is no financial support to our research from any organizations.

References

  1. Nadir SJ, Saleem N, Amin F (2011) Steroid sensitive nephritic syndrome in pediatrics. Park J Pharm Sci 24: 207-210.
  2. Skálová S, Podhola M, Vondrák K, Chernin G (2010) Steroid sensitive nephritic syndrome in pediatrics. Park J Pharm Sci 24: 207-210.
  3. Qin Q, Xu R, Dong J, Xia W, Sun R (2010) Ruopeng Sun.Evaluation of right ventricle function in children with primary nephrotic syndrome. Pediatr Neonatol 51: 166-171.
  4. Nakamura H, Takata S, Umemoto S, Matsuzaki M (2003) Induction of left ventricular remodeling and dysfunction in the recipient heart after donor heart myocardial infarction: new insights into the pathologic role of tumor necrosis factor-alpha from a novel heterotopic transplant-coronary ligation model. J Cardiol 41: 41-42.
  5. Correia Pinto J, Henriques-Coelho T, Roncon-Albuquerque Jr R, Leite-Moreira AF (2006) Differential right and left ventricular diastolic tolerance to acute afterload and NCX gene expression in Wistar rats. Physiol Res 55: 513-526.
  6. Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, et al. (1995) New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function - a study in normals and dilated cardiomyopathy. J Cardiol 26: 357-366.
  7. Harjai K, Scott L, Vivekananthan K, Nunez E, Edupuganti R (2002) The Tei index: A new prognostic index for patients with symptomatic heart failure. J Am Soc Echocardiogr 15 : 864-868.
  8. (2018) World Medical Association Declaration of Helsinki- Ethical Principles for Medical Research involving human subjects.
  9. Lindblad, YT, Axelsson J, Balzano R, Vavilis G, Chromek M, et al. (2013) Left ventricular diastolic dysfunction by tissue Doppler echocardiography in pediatric chronic kidney disease. Pediatr Nephrol 28: 2003-2013.
  10. Alpert MA, Bauer JH, Parker BM, Brooks CS, Freeman JA (1979) Pulmonary hemodynamics in systemic hypertension. Long-term effect of minoxidil. Chest 76: 379-383.
  11. Bagga A, Ali U, Banerjee S, Kanitkar M, Phadke KD, et al. (2008) Management of Steroid Sensitive Nephrotic Syndrome. Indian Pediatr 45: 203-211.
  12. Gulleroglu K, Yazar B, Sakalli H, Ozdemir H, Baskin E (2014) Clinical importance of mean platelet volume in children with nephrotic syndrome. Ren Fail 99: 663-665.
  13. Kocyigit I, Yilmaz MI, Simsek Y, Unal A, Sipahioglu MH, et al. (2013) The role of platelet activation in determining response to therapy in patients with primary nephrotic syndrome. Platelets 24: 474-479.
  14. Russo LM, Bakris GL, Comper WD (2002) Renal handling of albumin: a critical review of basic concepts and perspective. Am J Kidney Dis 39: 899-919.
  15. Johnstone LM, Jones CL, Grigg LE, Wilkinson JL, Walker RG, et al. (1996) Left ventricular abnormalities in children, adolescents and young adults with renal disease. Kidney Int 50: 998-1006.
  16. Matteucci MC, Wuhl E, Picca S, Mastrostefano A, Rinelli G, et al. (2006) Left ventricular geometry in children with mild to moderate chronic renal insufficiency. J Am Soc Nephrol 17: 218-226.
  17. Mitsnefes MM, Kimball TR, Border WL, Witt SA, Glascock BJ, et al. (2004) Impaired left ventricular diastolic function in children with chronic renal failure. Kidney Int 65: 1461-1466.
  18. Tei C, Dujardin KS, Hodge DO, Bailey KR, McGoon MD, et al. (1997) Doppler echocardiographic index for assessment of global right ventricular function. J Am Soc Echocardiogr 9: 838-847.
  19. Lilova MI, Velkovski IG, Topalov IB (2000) Thromboembolic complications in children with nephrotic syndrome in Bulgaria 15:74-78.
  20. Yock PG, Popp RL (1984) Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 70: 657-662.
  21. Egan JR, Butler TL, Au CG, Tan YM, North KN, et al. (2006) Myocardial water handling and the role of aquaporins. Biochim Biophys Acta 1758: 1043-1052.
Citation: Saleh SM, Elmaghraby KSM, Abdelfadil AM, Mohamed HS (2018) Myocardial Performance Index in Nephrotic Syndrome. J Clin Exp Cardiolog 9: 585.

Copyright: © 2018 Saleh SM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Top